Ciech in brief
Ciech is a listed company in the Chemicals industry, based in Poland. Its last known market value was $700 M (January 2024); there is no current figure. In the year to December 2022 it had sales of $1.2 B and a net profit of $127 M, about 10 cents of profit for every dollar of sales. Its shares trade under the symbol CHX.F (Frankfurt).
Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.
Ciech timeline
- 2001
- 🏁· approximateIncorporated as Qemetica Spółka Akcyjna
- 2014
- •Legal Entity Identifier issuedLEI 259400GYHYZPQ0HTMT82 registered.
- 2022
- 💰Revenue passed $1 billionFY2022 revenue of $1.2 billion, up from $902 million in FY2021.
- 2024
- ✎Renamed Qemetica Spółka AkcyjnaLegal name change recorded in the LEI register.
Events of Ciech from the GLEIF LEI register and the company's financial years. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
Market cap history
World rank over time
Rank in Poland: #18 (Jan 2020) · #22 (Jan 2021) · #30 (Jan 2022) · #37 (Dec 2022) · #39 (Jul 2023) · #34 (Jan 2024)
Key ratios
- P/E ratio
- —
- Price / sales
- —
- Price / book
- —
- Free cash flow yield
- —
- Net margin
- 10.5%
- Operating margin
- 10.9%
- Return on equity
- 20.6%
- Liabilities / assets
- 66.6%
- Revenue growth
- +34.6%
Financial history
| Fiscal year ending | Revenue | Growth | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| Dec 2022 | $1.2B | +34.6% | $132M | $127M | 10.5% |
| Dec 2021 | $902M | — | $88M | $73M | 8.1% |
Cash flow, debt and per share
| Fiscal year ending | Operating cash flow | Capital spending | Free cash flow | EPS (diluted) | Dividend / share |
|---|---|---|---|---|---|
| Dec 2022 | $189M | — | — | $241.18 | — |
| Dec 2021 | $327M | — | — | $138.52 | — |
Annual results
- Revenue
- $1.2 B
- Operating income
- $132 M
- Net income
- $127 M
For year ending December-2022 · source: official annual report (ESEF)
Balance sheet
- Total assets
- $1.8 B
- Total liabilities
- $1.2 B
- Total equity
- $616 M
As of December-2022
Ownership and subsidiaries
- Parent company
- Kulczyk Investments S.A.🇱🇺 Luxembourg
- CIECH Trading Spółka Akcyjna🇵🇱 Warszawa
- QEMETICA Energy Deutschland GmbH🇩🇪 Staßfurt
- QEMETICA NL Silica B.V.🇳🇱 Farmsum
- QEMETICA SODA POLSKA SPÓŁKA AKCYJNA🇵🇱 INOWROCŁAW
- QEMETICA Salz Deutschland GmbH🇩🇪 Staßfurt
- QEMETICA Soda Deutschland GmbH & Co. KG🇩🇪 Staßfurt
Ciech scorecard#
Passes 5 of the 5 checks that could be worked out. Fiscal year 2022.
Valuationnot known
- –P/E below its peers' medianNo market cap.
- –Price to book below its peers' medianNo market cap.
- –Price to sales below its peers' medianNo market cap.
- –Free cash flow yield above 5%No market cap.
- –Earnings yield above the 10-year Treasury yieldNo market cap.
- –The price assumes slower growth than the last three years'No market cap.
Growth2 of 2
- ✓Revenue grew in the newest year34.6%Revenue up 34.6% in fiscal 2022.
- –Revenue up more than 5% a year over three yearsRevenue of three years earlier is not on file.
- –Faster growth over three years than its peers' medianRevenue of three years earlier is not on file.
- ✓Earnings per share grew in the newest year241.18 vs 138.52Diluted EPS 241.18 in fiscal 2022 against 138.52 the year before (report's currency).
- –Net income higher than five years earlierNet income of five years earlier is not on file.
- –Revenue rose in at least four of the last five yearsFive years of revenue changes are not on file.
Profitability3 of 3
- ✓Profitable in the newest year$127 MNet income $127 M in fiscal 2022.
- –Profitable in each of the last five yearsFive years of net income are not on file.
- ✓Operating margin above its peers' median10.9%10.9% against Chemicals's median of 4.4% (73 companies).
- ✓Return on equity above 15%21.1%21.1% in fiscal 2022.
- –Return on invested capital above 10%No return on invested capital on file.
- –Operating margin wider than three years earlierOperating margins of three years earlier are not on file.
Financial healthnot known
- –Short-term assets cover short-term liabilitiesCurrent assets and liabilities are not on file.
- –Debt below equityDebt or equity is not on file (or equity is negative).
- –Net debt below three years of EBITDANet debt to EBITDA is not on file.
- –Operating income covers interest five timesInterest expense is not on file.
- –Cash from operations positive in each of the last three yearsThree years of operating cash flow are not on file.
- –Altman Z-score outside the distress zoneThe Z-score's figures are not all on file.
Shareholder returnsnot known
- –Pays a dividendDividends are not on file.
- –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
- –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
- –Share count up no more than 2% in a yearShare counts of two years are not on file.
- –Dividends and buybacks above 3% of the market valueNo market cap.
- –Free cash flow covers dividends and buybacksCash from operations or capital spending is not on file.
Worked out from the statements as filed (esef), the medians of Chemicals, the 10-year Treasury yield of Nov 13, 2026 and the market cap (too old for the valuation checks, which need one at most 60 days old). A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work
Ciech: financial statements#
Income statement, balance sheet and cash-flow statement as reported, newest period first.
Amounts in PLN millions; per-share figures in PLN; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).
| Period | Trend | FY 2022to Dec 31, 2022 | FY 2021to Dec 31, 2021 | FY 2020to Dec 31, 2020 | FY 2019to Dec 31, 2019 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | 5,415+55.5%100% | 3,484+17.1%100% | 2,976−8.2%100% | 3,242—100% | |
| Cost of revenue | 4,247+49.0%78.4% | 2,851+21.6%81.8% | 2,345−7.3%78.8% | 2,529—78.0% | |
| Gross profit | 1,168+84.8%21.6% | 632+0.3%18.2% | 631−11.5%21.2% | 713—22.0% | |
| General and administrative | 296+21.4%5.5% | 243+42.6%7.0% | 171−13.8%5.7% | 198—6.1% | |
| Operating income | 590+73.3%10.9% | 341+36.2%9.8% | 250−1.4%8.4% | 253—7.8% | |
| Interest and finance income | 188+604%3.5% | 27−54.3%0.8% | 58+1054%2.0% | 5.1—0.2% | |
| Interest expense and finance costs | 188+70.1%3.5% | 110−8.1%3.2% | 120+35.0%4.0% | 89—2.7% | |
| Income before tax | 592+130%10.9% | 257+36.5%7.4% | 188+10.2%6.3% | 171—5.3% | |
| Income tax | 27−28.1%0.5% | 38−42.0%1.1% | 65−0.7%2.2% | 65—2.0% | |
| Income from continuing operations | 565+158%10.4% | 219+78.0%6.3% | 123+17.0%4.1% | 105—3.2% | |
| Income from discontinued operations | 0−100%0.0% | 62+1177%1.8% | 4.8+26.8%0.2% | 3.8—0.1% | |
| Net income including minority interests | 565+101%10.4% | 281+120%8.1% | 128+17.4%4.3% | 109—3.4% | |
| Minority interests' share of net income | −2.2—−0.0% | −0.8—−0.0% | −1.2—−0.0% | −1.3—−0.0% | |
| Net income attributable to shareholders | 567+101%10.5% | 282+118%8.1% | 129+17.1%4.3% | 110—3.4% | |
| Earnings per share, basic | 10.76+101%— | 5.35+118%— | 2.45+17.2%— | 2.09—— | |
| Earnings per share, diluted | 10.76+101%— | 5.35+118%— | 2.45+17.2%— | 2.09—— | |
| Dividends per share | 1.50−50.0%— | 3.00—— | — | — | |
| Balance sheet | |||||
| Cash and cash equivalents | 685−14.3%8.5% | 799+80.0%11.2% | 444+48.2%7.8% | 300—5.9% | |
| Receivables | 805+43.2%9.9% | 562+23.3%7.9% | 456−13.2%8.0% | 525—10.4% | |
| Inventory | 772+68.0%9.5% | 459+31.6%6.4% | 349−23.4%6.1% | 456—9.0% | |
| Current assets | 3,192+36.0%39.4% | 2,348+61.2%32.9% | 1,456+11.0%25.5% | 1,312—26.0% | |
| Property, plant and equipment | 3,933+1.8%48.6% | 3,863+14.8%54.1% | 3,366+16.4%59.0% | 2,891—57.3% | |
| Goodwill | 152+1.7%1.9% | 149−0.3%2.1% | 150+7.3%2.6% | 140—2.8% | |
| Other intangible assets | 395+6.9%4.9% | 369−6.6%5.2% | 395+13.9%6.9% | 347—6.9% | |
| Non-current assets | 4,901+2.4%60.6% | 4,788+12.6%67.1% | 4,251+13.8%74.5% | 3,734—74.0% | |
| Total assets | 8,093+13.4%100% | 7,135+25.0%100% | 5,708+13.1%100% | 5,047—100% | |
| Accounts payable | 2,793+42.8%34.5% | 1,956+81.4%27.4% | 1,078+27.3%18.9% | 847—16.8% | |
| Current liabilities | 3,207+45.3%39.6% | 2,207−30.8%30.9% | 3,188+190%55.9% | 1,099—21.8% | |
| Lease liabilities (non-current) | 105−13.5%1.3% | 121+17.0%1.7% | 104−10.7%1.8% | 116—2.3% | |
| Non-current liabilities | 2,181−14.2%27.0% | 2,542+534%35.6% | 401−79.6%7.0% | 1,970—39.0% | |
| Total liabilities | 5,388+13.5%66.6% | 4,749+32.3%66.6% | 3,589+16.9%62.9% | 3,070—60.8% | |
| Retained earnings | 1,594+44.1%19.7% | 1,106+12.6%15.5% | 982−18.1%17.2% | 1,200—23.8% | |
| Shareholders' equity | 2,710+13.4%33.5% | 2,390+12.7%33.5% | 2,121+7.2%37.2% | 1,978—39.2% | |
| Minority interests | −5.9—−0.1% | −3.8—−0.1% | −2.1—−0.0% | −1.0—−0.0% | |
| Total equity | 2,704+13.3%33.4% | 2,386+12.6%33.4% | 2,119+7.2%37.1% | 1,977—39.2% | |
| Total liabilities and equity | 8,093+13.4%100% | 7,135+25.0%100% | 5,708+13.1%100% | 5,047—100% | |
| Cash-flow statement | |||||
| Depreciation and amortization | 431+15.1%8.0% | 375+10.6%10.8% | 339+9.1%11.4% | 310—9.6% | |
| Cash from operating activities | 842−33.3%15.6% | 1,264+64.7%36.3% | 767+43.3%25.8% | 535—16.5% | |
| Acquisitions, net of cash acquired | −4.9—−0.1% | −5.1—−0.1% | — | — | |
| Cash from investing activities | −845—−15.6% | −692—−19.9% | −834—−28.0% | −411—−12.7% | |
| Debt issued | 2.1−98.9%0.0% | 195−61.4%5.6% | 506+82.4%17.0% | 277—8.6% | |
| Debt repaid | 0—0.0% | −232—−6.7% | −263—−8.8% | −268—−8.3% | |
| Dividends paid | −79—−1.5% | −158—−4.5% | — | — | |
| Cash from financing activities | −110—−2.0% | −222−205%−6.4% | 212—7.1% | −17—−0.5% | |
| Exchange-rate effect on cash | −1.7−911%−0.0% | 0.2−95.0%0.0% | 4.3+4612%0.1% | 0.1—0.0% | |
| Report | ESEF | ESEF | ESEF | ESEF | |
Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.
Source: ESEF annual reports (filings.xbrl.org) · as of Dec 31, 2022. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative
Where Ciech operates: 3 countries#
Countries where the company has its headquarters, an office, subsidiaries, a branch or reported revenue. 6 subsidiaries on file.
| Country | Presence | Revenue there |
|---|---|---|
| 🇵🇱 Poland | Headquarters2 offices2 subsidiaries | — |
| 🇩🇪 Germany | 3 subsidiaries | — |
| 🇳🇱 Netherlands | 1 subsidiary | — |
Source: GLEIF legal-entity register, SEC Exhibit 21 and annual reports, office addresses on file. A country without subsidiaries or offices on record is not listed even if the company sells there. How presence is decided
How Ciech compares in Chemicals
- Revenue$1.2 B · higher than 51% of 421
- Net margin10.5% · higher than 65% of 409
- Revenue growth34.6% · higher than 95% of 111
- 🇯🇵 Kureha Corporation$1.1 B
- 🇧🇷 Unipar Carbocloro$820 M
- 🇨🇳 Guangdong Hongda Blasting$3.2 B
- 🇯🇵 Sanyo Chemical Industries, Ltd.$886 M
- 🇩🇪 SGL Carbon SE$602 M
- 🇺🇸 Ingevity Corporation$2.4 B
Peer comparison · Chemicals
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| Ciech🇵🇱 | $700 M | — | 10.5% | +34.6% |
| Linde plc🇬🇧 | $231.0 B | 33.0× | 19.3% | +3.0% |
| Air Liquide🇫🇷 | $124.8 B | 29.9× | 13.1% | +3.8% |
| The Sherwin-Williams Company🇺🇸 | $81.4 B | 30.4× | 10.7% | +2.1% |
| Ecolab Inc.🇺🇸 | $79.7 B | 38.3× | 12.0% | +2.2% |
| Shin-Etsu Chemical Co., Ltd.🇯🇵 | $74.3 B | 23.1× | 18.4% | — |
| Air Products and Chemicals, Inc.🇺🇸 | $66.5 B | — | -0.4% | -0.5% |
| Nan Ya Plastics Corporation🇹🇼 | $55.1 B | 372.9× | 1.7% | — |
| BASF SE🇩🇪 | $52.7 B | 27.4× | 2.7% | -18.8% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Questions people ask
Compare head to head
Similar companies by size and industry
- Linde plc$231.0 B
- Air Liquide$124.8 B
- The Sherwin-Williams Company$81.4 B
- Ecolab Inc.$79.7 B
- Shin-Etsu Chemical Co., Ltd.$74.3 B
- Air Products and Chemicals, Inc.$66.5 B
Sources and freshness
- Market cap:
- Jan 5, 2024 (last known)
- Annual results:
- For year ending December-2022
- Balance sheet:
- As of December-2022
- Profile updated:
- Nov 4, 2026
Figures from Official annual report (ESEF), value.today research, GLEIF register.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at Ciech? Verify and update this profile — free
Show Ciech's ranking or a chart on your website Get the badge
The badge updates itself as the ranking changes.